YVETTE MURILLO: Open Payments
NPI 1225363989 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$492 in 15 payments from 8 companies in 2025. Trend: 2023 $151 · 2024 $508 · 2025 $492
Food & beverage: $492
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 7 | $237 |
| Novo Nordisk Inc | 1 | $125 |
| Merck Sharp & Dohme LLC | 2 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $19 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
| Kedrion Biopharma, Inc. | 1 | $16 |
| EMD Serono, Inc. | 1 | $13 |
Products named: Enhertu, KEYTRUDA, ICLUSIG, VERZENIO, LEQVIO, Albuked.
Industry payments across NY — which companies pay providers there.
